Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00189592 · ClinicalTrials.gov registry record · Phase 4
Plantar Fasciosis Treatment Using Coblation
A Phase 4 study, sponsored by ArthroCare Corporation.
- Completed
- Registry status
- Phase 4
- Development phase
- 45
- Enrollment target
NCT00189592: Completed Phase 4 study, sponsored by ArthroCare Corporation.
NCT00189592 is a Phase 4 study that has completed, run by ArthroCare Corporation. The registered enrollment target is 45 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00189592, a Phase 4 study, has completed, sponsored by ArthroCare Corporation.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 45 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness of Coblation-based fasciotomy for relieving pain associated with recurring plantar fasciosis and, secondarily, to determine whether there may be additional potential benefits stemming from its use.
Interventions
- DEVICE ArthroCare TOPAZ™ MicroDebrider™ using Coblation
- PROCEDURE Surgical Fasciotomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2005-08 |
| Est. Completion | 2008-06 |
| Phase | Phase 4 |
What the finished NCT00189592 record still lists
NCT00189592 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 2 interventions - of which ArthroCare TOPAZ™ MicroDebrider™ using Coblation is the first listed.
NCT00189592 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00189592 about?
NCT00189592 is a clinical study titled "Plantar Fasciosis Treatment Using Coblation". The purpose of this study is to evaluate the effectiveness of Coblation-based fasciotomy for relieving pain associated with recurring plantar fasciosis and, secondarily, to determine whether there may be additional potential benefits stemming from its use.
What is the current status of trial NCT00189592?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 45 participants. The study started on 2005-08. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00189592?
The interventions under investigation include: ArthroCare TOPAZ™ MicroDebrider™ using Coblation (DEVICE), Surgical Fasciotomy (PROCEDURE).
Who is sponsoring clinical trial NCT00189592?
This trial is sponsored by ArthroCare Corporation, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00189592's enrollment target sits among peer trials
45 1354th of 2000 higher than 638 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia